The World Health Expo Lagos 2026 is set to return from June 2 to 4 at the Landmark Centre, marking a key moment for healthcare investment in West Africa. Nigeria, home to the region's largest healthcare market, is seeing a projected sector growth of 7.1 percent, with an estimated value of 161.7 million dollars by 2027. This expansion is supported by a 1.2 billion dollar federal government investment aimed at upgrading infrastructure and developing healthcare personnel. The Nigeria Sovereign Investment Authority is also advancing oncology and diagnostic services. Regional trade under the African Continental Free Trade Area is improving access to medical goods and services. Despite progress, 70 percent of Nigerians still pay for healthcare out of pocket, underscoring ongoing access and financing gaps. Nigeria's medical device market is expected to grow from 414.8 million dollars in 2025 to over 632 million dollars by 2030. Countries like Ghana, Senegal, Cameroon, and Ivory Coast are also expanding their healthcare systems through hospital upgrades and digital diagnostics. The WHX event will host over 500 exhibitors and 8,000 professional visitors from 40 countries. Njide Ndili, President of the Healthcare Federation of Nigeria, emphasized the role of WHX in aligning market access with national health goals. The event includes leadership forums on regulatory alignment, investment, and diagnostics, including a laboratory forum with the Medical Laboratory Science Council of Nigeria. Tom Coleman, Portfolio Director for Healthcare at Informa Markets, described WHX as a space where policy translates into collaboration.
Njide Ndili's emphasis on market access dialogue as a driver of transformation reveals a quiet pivot in Nigeria's healthcare strategy — one where private sector coordination is now as critical as government spending. The 1.2 billion dollar federal investment is substantial, but the real shift lies in how institutions like the Healthcare Federation of Nigeria are being positioned to shape policy outcomes through platforms like WHX.
This is not just about medical equipment or hospital upgrades; it's about positioning Nigeria as a commercial hub for healthcare in West Africa. With AfCFTA enabling smoother cross-border movement of medical goods, the focus on regulatory harmonisation and investment forums suggests a long-term play to integrate Nigeria's health economy with its neighbours. The inclusion of the Medical Laboratory Science Council of Nigeria in a dedicated diagnostics forum signals an attempt to standardise quality across borders, not just boost supply.
For ordinary Nigerians, especially the 70 percent who still pay out of pocket, the immediate impact remains uncertain. While expanded diagnostics and hospital financing may improve care over time, the benefits are likely to reach urban professionals and private patients first. Rural populations and informal workers may see little change unless these investments are deliberately extended beyond commercial corridors.
The WHX return fits a broader pattern: Nigeria increasingly relying on public-private convergence to tackle systemic challenges. From power to transport, the model is consistent — government sets the stage, but private actors and regional markets drive execution. Healthcare is now following the same script.
